Diagnosis and Management of Intraabdominal Infection: Guidelines by the Chinese Society of Surgical Infection and Intensive Care and the Chinese College of Gastrointestinal Fistula Surgeons. (23rd December 2020)

• Record Type: Journal Article
• Authors: Wu, Xiuwen; Wu, Jie; Wang, Peige; Fang, Xueling; Yu, Yunsong; Tang, Jianguo; Xiao, Yonghong; Wang, Minggui; Li, Shikuan; Zhang, Yun; Hu, Bijie; Ma, Tao; Li, Qiang; Wang, Zhiming; Wu, Anhua; Liu, Chang; Dai, Menghua; Ma, Xiaochun; Yi, Huimin; Kang, Yan; Wang, Daorong; Han, Gang; Zhang, Ping; Wang, Jianzhong; Yuan, Yufeng; Wang, Dong; Wang, Jian; Zhou, Zheng; Ren, Zeqiang; Liu, Yuxiu; Guan, Xiangdong; Ren, Jianan;
• Is Part Of: Clinical infectious diseases. Volume 71(2020)Supplement 4
• Page Start: S337
• Page End: S362
• Publication Date: 2020-12-23
• Subjects: intraabdominal infection -- source control -- antimicrobial therapy -- nutrition -- treatment failure; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciaa1513
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: The Chinese guidelines for IAI presented here were developed by a panel that included experts from the fields of surgery, critical care, microbiology, infection control, pharmacology, and evidence-based medicine. All questions were structured in population, intervention, comparison, and outcomes format, and evidence profiles were generated. Recommendations were generated following the principles of the Grading of Recommendations Assessment, Development, and Evaluation system or Best Practice Statement (BPS), when applicable. The final guidelines include 45 graded recommendations and 17 BPSs, including the classification of disease severity, diagnosis, source control, antimicrobial therapy, microbiologic evaluation, nutritional therapy, other supportive therapies, diagnosis and management of specific IAIs, and recognition and management of source control failure. Recommendations on fluid resuscitation and organ support therapy could not be formulated and thus were not included. Accordingly, additional high-quality clinical studies should be performed in the future to address the clinicians' concerns.